Aurinia Pharmaceuticals Inc. (AUPH) NASDAQ
Currency In USD
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
Valuation
| Market Cap | 2.14B |
| Enterprise Value | 2.14B |
| P/E Ratio | 6.82 |
| PEG Ratio | 0.02 |
| Price/Sales Ratio | 6.65 |
| Price/Book Ratio | 3.41 |
| Enterprise/Revenue | 6.26 |
| Enterprise/EBITDA | 10.37 |
Fiscal Year
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | June 30, 2026 |
Profitability
| Profit Margin | 1.01 |
| Operating Margin | 0.48 |
AD
Management Effectiveness
| Return On Assets | 0.4 |
| Return On Equity | 0.59 |
Income Statement
| Revenue | 283.06M |
| Revenue/Share | 2.39 |
| Gross Profit | 250.39M |
| EBITDA | 127.76M |
| Net Income | 287.2M |
| Diluted EPS | 2.07 |
Balance Sheet
| Total Cash | 443.12M |
| Total Cash/Share | 3.41 |
| Total Debt | 60.42M |
| Total Debt/Equity | 0.1 |
| Current Ratio | 5.42 |
| Book Value Per Share | 4.73 |
Price History
| 52-Week Change | 25.98 |
| 52-Week High | 19.25 |
| 52-Week Low | 10.34 |
| Moving Average 50 Days | 15.8 |
| Moving Average 200 Days | 15.5 |
Statistics
| Average Volume | 1.38M |
| Shares Outstanding | 128.6M |
| % Held by Institutions | 61.02 |
Dividend And Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | 1:50 |
| Last Split Date | October 23, 2013 |
AD
